Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094393 · ClinicalTrials.gov registry record
Clinical Studies of Progeria
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 15
- Enrollment target
NCT00094393: Completed study, sponsored by National Human Genome Research Institute (NHGRI).
NCT00094393 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00094393 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This study will examine children with Hutchinson-Gilford Progeria syndrome, a genetic disease that causes many changes to the body over time, including heart disease, bone changes, hair loss, and joint and skin changes. Often called a "premature aging" disease, progeria does not mimic aging completely. This study will examine which body systems are affected in progeria and how each system is affected over time in order to try to develop new treatments. Patients with progeria who are between 6 months and 70 years of age and who are able to travel to the NIH in Bethesda, Md., may be eligible for this 5- to 10-year study. Participants come to the NIH Clinical Center for evaluation every 2 years. Each 4-5 day visit includes the following tests and procedures: * Medical history and physical examination * Blood tests to analyze cardiovascular risk factors, blood counts, blood chemistries, and for research * Urine tests for sugar and proteins * Photographs to study growth problems * X-ray studies to determine bone density and body composition, such as body fat and muscle * Electrocardiogram (EKG) and echocardiogram (heart ultrasound) to study the heart and blood vessels * Lung function tests to measure energy consumption and lung capacity * Skin biopsy (surgical removal of a small skin sample) to examine cellular changes * Hearing tests * Eye examination to evaluate eyesight, eye pressure and structures of the eye * Physical therapy evaluation with stretching and exercises to measure how the joints bend and straighten * Dental examination, including X-rays * Meeting with a nutritionist who will track the patient's food intake and take body measurements * Magnetic resonance imaging (MRI) for patients who are old enough to undergo the procedure without sedation. This test uses a magnetic field and radio waves to examine body organs. For this test, the patient must lie still in the scanner, a narrow cylindrical tube. Patients are provided the results of their medical test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2004-10-14 |
| Est. Completion | 2018-05-22 |
What the finished NCT00094393 record still lists
NCT00094393 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00094393 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00094393 about?
NCT00094393 is a clinical study titled "Clinical Studies of Progeria". This study will examine children with Hutchinson-Gilford Progeria syndrome, a genetic disease that causes many changes to the body over time, including heart disease, bone changes, hair loss, and joint and skin changes. Often called a "premature aging" disease, progeria does not mimic aging complete...
What is the current status of trial NCT00094393?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2004-10-14. Estimated completion is 2018-05-22.
Who is sponsoring clinical trial NCT00094393?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI